image
Kiniksa Pharmaceuticals, Ltd. KNSA
Healthcare - Biotechnology - NASDAQ - BM
Watchlist
$ 21.29
-2.38 %
$ 1.54 B
Market Cap
-177.42
P/E
BALANCE SHEET
526 M ASSETS
14.50%
Growth Rates
1Year 14.50%
3Years 14.63%
5Years 10.33%
7Years 37.56%
10Years 0.00%
87.5 M LIABILITIES
37.72%
Growth Rates
1Year 37.72%
3Years 32.59%
5Years 15.43%
7Years 0.89%
10Years 0.00%
439 M EQUITY
189.19%
Growth Rates
1Year 189.19%
3Years 41.75%
5Years 33.62%
7Years 52.35%
10Years 0.00%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Kiniksa Pharmaceuticals, Ltd.
image
Current Assets 276 M
Cash & Short-Term Investments 206 M
Receivables 21.3 M
Other Current Assets 48.7 M
Non-Current Assets 250 M
Long-Term Investments 0
PP&E 12.7 M
Other Non-Current Assets 237 M
Current Liabilities 63.7 M
Accounts Payable 8.25 M
Short-Term Debt 4.51 M
Other Current Liabilities 50.9 M
Non-Current Liabilities 23.8 M
Long-Term Debt 10 M
Other Non-Current Liabilities 13.8 M

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016
ASSETS
Cash & Cash Equivalents 108.0 122.7 122.5 114.0 46.9 307.3 45.6 56.0
Short Term Investments 98.4 67.9 59.7 209.4 186.5 235.3 0 0
Receivables 21.3 20.3 4.0 0 0 0 0 0
Inventory 31.1 21.6 3.7 0 0 0 0 0
Other Current Assets 17.5 10.5 13.2 9.8 16.5 12.9 1.5 0.4
Total Current Assets 276.3 243.1 196.4 333.2 241.6 313.8 47.1 56.3
PP&E 12.7 7.0 8.4 10.6 8.3 6.4 0.1 84 K
Intangible Assets 17.2 18.2 19.2 0 0 0 0 0
Goodwill 0 0 0 0 0 0 0 0
Long Term Investments 0 0 0 0 0.2 0.2 0 0
Other Long Term Assets 0.8 5.8 8.7 5.6 0.2 0.6 25 K 8 K
Other Assets 0 0 0 0 0 0 0 0
Total Assets 526.3 459.7 232.8 349.5 254.5 322.0 47.5 56.5
LIABILITIES
Accounts Payable 8.2 7.9 1.9 0.5 5.7 10.9 1.2 0.2
Short Term Debt 4.5 6.6 6.8 4.2 3.4 0 0 0
Other Current Liabilities 50.6 32.6 36.2 27.1 18.7 31.6 16.2 2.1
Total Current Liabilities 63.7 47.1 44.8 31.8 27.8 42.6 17.4 2.3
Long Term Debt 10.0 2.6 2.7 4.9 1.0 0 0 0
Deferred Tax Income 0 0 0 0 0 1.2 0 0
Other Liabilities 1.9 1.8 0.3 0.8 0.3 0.1 119.8 79.9
Total Liabilities 87.5 63.5 47.8 37.5 29.1 42.7 137.2 82.2
EQUITY
Common Stock 20 K 19 K 18 K 18 K 15 K 13 K 1 K 1 K
Retained Earnings (477.9) (492.0) (675.4) (517.5) (356.1) (194.2) (91.0) (26.1)
Other Accumulative Comprehensive Income/Loss 6 K 44 K 66 K 34 K 33 K 4 K 52 K 24 K
Total Equity 438.8 (492.0) (675.4) (517.5) (356.1) (194.2) (89.7) (25.7)
Total Liabilities and Equity 526.3 (428.5) (627.6) (479.9) (327.0) (151.5) 47.5 56.5
SHARES OUTSTANDING
Common Shares Outstanding 70.1 69.4 68.6 61.8 54.0 29.5 32.5 32.5